Emergent BioSolutions Initiates Phase 1 Study Evaluating
GAITHERSBURG, Md., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has dosed the first participant in...
Source: globenewswire.com
Stay updated with breaking news from Profectus Lassa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GAITHERSBURG, Md., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has dosed the first participant in...